The Law Offices of Frank R. Cruz is investigating Stryker Corporation for possible securities law violations after supply disruptions led to significant backorders and lost sales, causing the stock to drop sharply in July and September 2026. The company initially expected the issue to resolve by Q3 but later admitted it would continue, further impacting investor confidence and share price. Investors who suffered losses are encouraged to contact the law firm to explore claims for recovery.
Stryker Corporation (SYK) holds a market cap of $108.38 billion and a dividend yield of 1.25% as of Oct 15, 2026, 04:11 WIB. Despite the ongoing securities fraud investigation linked to supply disruptions, the stock shows a modest 0.34% decline in one day on Pluang, with a trading volume of 2,068,363 shares. Investor interest remains strong, reflected by 100% buy orders on the platform and a typical holding period of 22 days.
Stryker has received FDA 510(k) clearance for Sonopet 3, its latest ultrasonic bone and soft tissue removal platform developed with surgeon input. The device offers enhanced power, precision, and versatility, featuring new technologies like RISE for ...
Pomerantz LLP is investigating Stryker Corp. for potential securities fraud after the company revealed ongoing manufacturing problems in its peripheral vascular business. The issue, initially expected to be resolved in Q3 2026, has persisted into Q4,...
